{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:20:15Z","timestamp":1784164815545,"version":"3.55.0"},"reference-count":23,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2197,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1111\/j.1365-2354.2009.01135.x","type":"journal-article","created":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T04:07:56Z","timestamp":1251259676000},"page":"755-760","source":"Crossref","is-referenced-by-count":89,"title":["The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain"],"prefix":"10.1155","volume":"19","author":[{"given":"R.D.","family":"POCKETT","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"CASTELLANO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"MCEWAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"OGLESBY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.L.","family":"BARBER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"CHUNG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,8,26]]},"reference":[{"issue":"5","key":"10.1111\/j.1365-2354.2009.01135.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"v9","DOI":"10.1093\/annonc\/mdg750","article-title":"Survival of cancer patients in Europe: the EUROCARE-3 Study","volume":"14","author":"Berrino","year":"2003","journal-title":"Annals of Oncology"},{"key":"10.1111\/j.1365-2354.2009.01135.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1200\/JCO.2006.05.9212","article-title":"Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy","volume":"24","author":"Clemons","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"10.1111\/j.1365-2354.2009.01135.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","article-title":"Metastatic bone disease: clinical features, pathophysiology and treatment strategies","volume":"27","author":"Coleman","year":"2001","journal-title":"Cancer Treatment Reviews"},{"issue":"1","key":"10.1111\/j.1365-2354.2009.01135.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.breast.2004.09.004","article-title":"The role of bisphosphonates in breast cancer","volume":"13","author":"Coleman","year":"2004","journal-title":"Breast"},{"key":"10.1111\/j.1365-2354.2009.01135.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/bjc.1987.13","article-title":"The clinical course of bone metastases from breast cancer","volume":"55","author":"Coleman","year":"1987","journal-title":"British Journal of Cancer"},{"issue":"6","key":"10.1111\/j.1365-2354.2009.01135.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0093-7754(01)90260-X","article-title":"The role of zoledronic acid in cancer: clinical studies in the treatment and prevention of bone metastases","volume":"28","author":"Coleman","year":"2001","journal-title":"Seminars in Oncololgy"},{"key":"10.1111\/j.1365-2354.2009.01135.x-BIB7|cit7","first-page":"341","article-title":"Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice","volume":"4","author":"Delea","year":"2006","journal-title":"Journal of Support Oncololgy"},{"key":"10.1111\/j.1365-2354.2009.01135.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00520-006-0203-x","article-title":"Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer","volume":"15","author":"DePuy","year":"2007","journal-title":"Support Care Cancer"},{"key":"10.1111\/j.1365-2354.2009.01135.x-BIB9|cit9","volume-title":"GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide","author":"Ferlay","year":"2004"},{"key":"10.1111\/j.1365-2354.2009.01135.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1016\/j.ejca.2003.09.004","article-title":"Cancer survival in European adolescents and young adults","volume":"39","author":"Gatta","year":"2003","journal-title":"European Journal of Cancer"},{"key":"10.1111\/j.1365-2354.2009.01135.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0302-2838(03)00007-1","article-title":"Costs of prostate cancer, metastatic to the bone, in the Netherlands","volume":"43","author":"Groot","year":"2003","journal-title":"European Urology"},{"key":"10.1111\/j.1365-2354.2009.01135.x-BIB12|cit12","first-page":"742","article-title":"Chemotherapy for metastatic breast cancer [Japanese]","volume":"33","author":"Ito","year":"2006","journal-title":"Japanese Journal of Cancer & Chemotherapy"},{"key":"10.1111\/j.1365-2354.2009.01135.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2354.2006.00771.x","article-title":"Quality of life in metastatic breast cancer patients under chemotherapy or supportive care: a single-institution comparative study","volume":"16","author":"Karamouzis","year":"2007","journal-title":"European Journal of Cancer Care"},{"key":"10.1111\/j.1365-2354.2009.01135.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11864-005-0023-0","article-title":"Management of bone metastases in breast cancer","volume":"6","author":"Lipton","year":"2005","journal-title":"Current Treatment Options in Oncology"},{"key":"10.1111\/j.1365-2354.2009.01135.x-BIB15|cit15","first-page":"165","article-title":"Situation of cancer in Spain: incidence","volume":"27","author":"L\u00f3pez","year":"2004","journal-title":"An Sis Sanit Navar"},{"key":"10.1111\/j.1365-2354.2009.01135.x-BIB16|cit16","volume-title":"The Situation of Cancer in Spain","author":"L\u00f3pez","year":"2005"},{"issue":"11","key":"10.1111\/j.1365-2354.2009.01135.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0093-7754(01)90228-3","article-title":"Analysis of skeletal-related events in breast cancer and response to therapy","volume":"28","author":"Lorusso","year":"2001","journal-title":"Seminars in Oncology"},{"key":"10.1111\/j.1365-2354.2009.01135.x-BIB18|cit18","first-page":"1221","article-title":"The quality of life of patients with cancer receiving hospice care","volume":"23","author":"McMillan","year":"1996","journal-title":"Oncology Nursing Forum"},{"key":"10.1111\/j.1365-2354.2009.01135.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/1471-2407-6-179","article-title":"Clinical management of women with metastatic breast cancer: a descriptive study according to age group","volume":"6","author":"Manders","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1111\/j.1365-2354.2009.01135.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nature Reviews Cancer"},{"key":"10.1111\/j.1365-2354.2009.01135.x-BIB21|cit21","unstructured":"National Center for Epidemiology 1996 Cancer mortality in Spain. Years 1996-2002 http:\/\/www.iscii.es\/"},{"key":"10.1111\/j.1365-2354.2009.01135.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/sj.bjc.6602551","article-title":"Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised crossover study of community vs hospital bisphosphanate administration","volume":"92","author":"Wardley","year":"2005","journal-title":"British Journal of Cancer"},{"key":"10.1111\/j.1365-2354.2009.01135.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/annonc\/mdi122","article-title":"The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer","volume":"16","author":"Weinfurt","year":"2005","journal-title":"Annals of Oncology"}],"container-title":["European Journal of Cancer Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2354.2009.01135.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2354.2009.01135.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T13:10:18Z","timestamp":1671541818000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2354.2009.01135.x"}},"subtitle":["Hospital burden associated with MBD and SREs in Spain"],"short-title":[],"issued":{"date-parts":[[2009,8,26]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2354.2009.01135.x","relation":{},"ISSN":["0961-5423"],"issn-type":[{"value":"0961-5423","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8,26]]}}}